Novavax Initiates Phase 2 Portion of Phase 1/2 Clinical Trial of COVID-19 Vaccine

NEXT STORY
Artificial Tears Market to Reach USD 4.30 Billion by 2027; Increasing Knowledge about Conjunctivitis and Other Eye Disorders to Foster Growth, states Fortune Business Insights™
PREV STORY
GeoVax Announces Clinical Trial Initiation of Novel Combination Therapy Utilizing MVA62B to Induce Remission in HIV-Positive Patients
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Fate Therapeutics Reports Third Quarter 2020 Financial Results and Highlights Operational Progress

author_avatar
NASDAQ Market News

Global Electrosurgical Devices Market Report 2018: Market is Expected to Reach US$ 8,000.9 Mn in 2025 from US$ 4,828.4 Mn in 2017

Dublin, Nov. 28, 2018 (GLOBE NEWSWIRE) -- The "Electrosurgical Devices Market to 2025 - ...

author_avatar
NASDAQ Market News

G1 Therapeutics to Report Fourth Quarter and Full-Year 2018 Financial Results on February 28, 2019

author_avatar
NASDAQ Market News